| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | MNMD | Stock Option (Right to Buy) | Jan 1, 2022 | Subordinate Voting Shares | 16.3K | $2.38 | Direct | F1, F2 | ||||||
| holding | MNMD | Directors' Deferred Share Units | Jan 1, 2022 | Subordinate Voting Shares | 11.5K | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The shares underlying the option shall vest and become exercisable in 12 equal monthly installments beginning on September 29, 2021, subject to the Reporting Person providing continuous service to the Issuer on each such date. |
| F2 | The option grant has an exercise price of $3.02 Canadian Dollars. This represents the exercise price in United States Dollars. |
| F3 | Represents Directors' Deferred Share Units ("DDSUs") granted pursuant to the Issuer's Directors' Deferred Share Unit Plan (the "Plan"), effective as of April 16, 2021. The DDSUs vest in equal monthly installments over 12 months beginning on September 29, 2021. The DDSUs acquired are to be settled in cash upon the termination of the Reporting Persons' directorship (with each DDSU representing the right to receive the cash equivalent of the fair market value of one Subordinate Voting Share). Pursuant to the Plan, the fair market value of a Subordinate Voting Share is equal to the volume weighted average trading price of a Subordinate Voting Share on the NEO exchange for the five business days immediately preceding the DDSUs vesting date. The DDSUs granted will expire no later than 90 days after the Reporting Person's termination date or such other reasonable time as may be determined by the Administrators (as defined in the Plan). |
No Table I securities beneficially owned Exhibit List - Exhibit 24 - Power of Attorney